Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effect of donor human milk on host-gut microbiota and metabolic interactions in preterm infants

  • Piñeiro Ramos, José David
  • Parra Llorca, Anna
  • Ten Doménech, Isabel
  • Gormaz, María
  • Ramón Beltrán, Amparo
  • Cernada, María
  • Quintas, Guillermo
  • Collado, María Carmen
  • Kuligowski, Julia
  • Vento, Máximo
Background & aims: Human milk is the gold standard for infant nutrition. Preterm infants whose mothers are unable to provide sufficient own mother's milk (OMM), receive pasteurized donor human milk (DHM). We studied metabolic signatures of OMM and DHM and their effect on the interplay of the developing microbiota and infant's metabolism. Methods: Metabolic fingerprinting of OMM and DHM as well as infant's urine was performed using liquid chromatography–mass spectrometry and the infant's stool microbiota was analyzed by 16S rRNA sequencing. Results: Significant differences in the galactose and starch and sucrose metabolism pathways when comparing OMM and DHM, and alterations of the steroid hormone synthesis and pyrimidine metabolism pathways in urine were observed depending on the type of feeding. Differences in the gut-microbiota composition were also identified. Conclusion: The composition of DHM differs from OMM and feeding of DHM has a significant impact on the metabolic phenotype and microbiota of preterm infants. Our data help to understand the origin of the observed changes generating new hypothesis: i) steroid hormones present in HM have a significant influence in the activity of the steroid hormone biosynthesis pathway in preterm infants; ii) the pyrimidine metabolism is modulated in preterm infants by the activity of gut-microbiota. Short- and long-term implications of the observed changes for preterm infants need to be assessed in further studies., This work was supported by the Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Spain [grant numbers CD19/00176, CM18/00165, and CP16/00034]; and the European Union's Horizon 2020 Research and Innovation Programme through the Nutrishield project (https://nutrishield-project.eu/) [Grant Agreement No 818110]. MCC would like to acknowledge the support from the European Research Council (ERC) Starting Grant [Grant Agreement No. 639226]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fast profiling of primary, secondary, conjugated, and sulfated bile acids in human urine and murine feces samples

  • Ramos García, Victoria
  • Ten Doménech, Isabel
  • Vento, Máximo
  • Bullich Vilarrubias, Clara
  • Romaní Pérez, Marina
  • Sanz Herranz, Yolanda
  • Nobili, Angelica
  • Falcone, Marika
  • Di Stefano, Marina
  • Quintás, Guillermo
  • Kuligowski, Julia
Bile acids (BAs) are a complex class of metabolites that have been described as specific biomarkers of gut microbiota activity. The development of analytical methods allowing the quantification of an ample spectrum of BAs in different biological matrices is needed to enable a wider implementation of BAs as complementary measures in studies investigating the functional role of the gut microbiota. This work presents results from the validation of a targeted ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for the determination of 28 BAs and six sulfated BAs, covering primary, secondary, and conjugated BAs. The analysis of 73 urine and 20 feces samples was used to test the applicability of the method. Concentrations of BAs in human urine and murine feces were reported, ranging from 0.5 to 50 nmol/g creatinine and from 0.012 to 332 nmol/g, respectively. Seventy-nine percent of BAs present in human urine samples corresponded to secondary conjugated BAs, while 69% of BAs present in murine feces corresponded to primary conjugated BAs. Glycocholic acid sulfate (GCA-S) was the most abundant BA in human urine samples, while taurolithocholic acid was the lowest concentrated compound detected. In murine feces, the most abundant BAs were α-murocholic, deoxycholic, dehydrocholic, and β-murocholic acids, while GCA-S was the lowest concentrated BA. The presented method is a non-invasive approach for the simultaneous assessment of BAs and sulfated BAs in urine and feces samples, and the results will serve as a knowledge base for future translational studies focusing on the role of the microbiota in health., This work was funded by the European Union’s Horizon 2020 Research and Innovation Programme through the Nutrishield project (https://nutrishield-project.eu/) [Grant Agreement No 818110] and the Carlos III Health Institute (Ministry of Science and Innovation, Spain) and co-funded by the European Union [grant numbers CD19/00176, and CPII21/00003], grant Despega IATA from IATA-CSIC, the Spanish Ministry of Science and Innovation [grant number PID2020-119536RB-I00], and MCIN/AEI/https://doi.org/10.13039/501100011033 and by ERDF A way of making Europe, by the “European Union” [grant number PID2021-125573OB-I00]., Peer reviewed